Litigation Details for IBSA Institut Biochimique SA v. Teva Pharmaceutical USA, Inc. (D. Del. 2019)
✉ Email this page to a colleague
IBSA Institut Biochimique SA v. Teva Pharmaceutical USA, Inc. (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-11-08 |
Court | District Court, D. Delaware | Date Terminated | 2020-01-03 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,691,411; 7,723,390 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in IBSA Institut Biochimique SA v. Teva Pharmaceutical USA, Inc.
Details for IBSA Institut Biochimique SA v. Teva Pharmaceutical USA, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-01-02 | 11 | Order | Granting 9 Joint STIPULATION regarding U.S. Patent No. 7,723,390. Signed by Judge Richard G. Andrews on 1…2019 3 January 2020 1:19-cv-02115 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-01-07 | 12 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,691,411 B2; 7,723,390 B2. (…2019 3 January 2020 1:19-cv-02115 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |